Clinical Trials Browser

Phase 3 × Has announcements × belantamab mafodotin × Clear all

NCT04246047 2026-04-23

DREAMM 7

Phase 3 Active not recruiting

494 enrolled 10 charts 1 FDA

Multiple Myeloma